Genomtec S.A. (WSE:GMT)
Poland
· Delayed Price · Currency is PLN 7.79
+0.34 (4.56%)
Mar 26, 2025, 4:41 PM CET
Genomtec Market Cap
Genomtec has a market cap or net worth of 105.53 million as of March 26, 2025. Its market cap has decreased by -14.76% in one year.
Market Cap
105.53M
Enterprise Value
102.40M
Revenue
1,000.00
Ranking
n/a
PE Ratio
n/a
Stock Price
7.79
Market Cap Chart
Since March 17, 2021, Genomtec's market cap has decreased from 110.55M to 105.53M, a decrease of -4.54%. That is a compound annual growth rate of -1.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2025 | 99.27M | -5.22% |
| Dec 30, 2024 | 104.73M | -21.25% |
| Dec 29, 2023 | 133.00M | 22.23% |
| Dec 30, 2022 | 108.81M | 42.64% |
| Dec 30, 2021 | 76.28M | -31.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NEUCA | 3.69B |
| Synektik Spólka Akcyjna | 1.82B |
| Celon Pharma | 1.51B |
| Voxel | 1.47B |
| Selvita | 786.53M |
| Centrum Medyczne ENEL-MED | 562.78M |
| Ryvu Therapeutics | 508.64M |
| Scope Fluidics | 503.75M |